X-9688194-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_005647.4(TBL1X):c.535T>C(p.Ser179Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000923 in 1,083,828 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_005647.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBL1X | NM_005647.4 | c.535T>C | p.Ser179Pro | missense_variant | 7/18 | ENST00000645353.2 | |
TBL1X | NM_001139466.1 | c.535T>C | p.Ser179Pro | missense_variant | 7/18 | ||
TBL1X | NM_001139467.1 | c.382T>C | p.Ser128Pro | missense_variant | 6/17 | ||
TBL1X | NM_001139468.1 | c.382T>C | p.Ser128Pro | missense_variant | 7/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBL1X | ENST00000645353.2 | c.535T>C | p.Ser179Pro | missense_variant | 7/18 | NM_005647.4 |
Frequencies
GnomAD3 genomes ? AF: 0.00 AC: 1AN: 111947Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34131 FAILED QC
GnomAD3 exomes AF: 0.00000661 AC: 1AN: 151206Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 46346
GnomAD4 exome AF: 0.00000923 AC: 10AN: 1083828Hom.: 0 Cov.: 32 AF XY: 0.0000113 AC XY: 4AN XY: 353086
GnomAD4 genome ? Data not reliable, filtered out with message: AS_VQSR AF: 0.00000893 AC: 1AN: 111947Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34131
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 16, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at